Our Mission

NGoggle’s goal is to promote neurodiagnostics and treatment with non-invasive BCI.  We envision wearable BCI systems to monitor and expedite the diagnosis and treatment of neurodegenerative diseases.

The Company’s aim is to license its NeuroDX platform – an embedded EEG Virtual Reality (VR) head mount device for neuro-stimulation and feedback.

Based in San Diego, NGoggle is “consumerizing” BCI one obstacle at at time: it holds several patents in the miniaturization of sensors, software noise / artifact removal techniques, and machine/deep learning algorithms for detecting and tracking ophthalmic disease progression.

Our Founders

(CEO), SB-EE, MBA

Kye Cheung

  • Founder of several companies Graphiti, CommASIC, NeoPoint, and previously President of Impeto Medical
JD

Stanley Kim

• Entrepreneur & Lawyer
• Founder of several companies including SoftMax

 

 

 

Chief Designer

David Morelock

• Adjunct Professor, New School of Architecture and Design
• Founder, Southern California Design Company
MD, PhD

Felipe A. Medeiros

• Vice Chair Department of Ophthalmology, Duke University
• Advisory Board Member, World Glaucoma Association
PhD, SMIEEE

John K. Zao

• Associate Director, UCSD Swartz Center for Computational Neuroscience
• Founder, SoftMax & SigMed

Our Advisors

Board Observer

Kfir Azoulay

• VP/ Head of Corporate Strategy at Heidelberg Engineering
PhD FIEEE

Tzzy-Ping Jung

  • Associate Director, UCSD Swartz Center for Computational Neuroscience
  • Founder, SoftMax & SigMed
PhD, FDA Expert

David Eveleth

• Managing Director at E&B Technologies, LLC
• CEO of Trefoil Therapeutics LLC
• Headed Ophthalmology Medicines Development Group at Pfizer
Display Expert, PhD

Yi-Pai Huang

• Professor, NCTU Photonics
• Taipei Chapter Chairman, Society of Information Display (SID)